Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Bullboard Posts
Comment by Creedmanon Jul 07, 2017 1:24pm
63 Views
Post# 26444667

RE:RE:RE:RE:Sector

RE:RE:RE:RE:SectorThis is a very good point.

DiligentSon wrote: I'm my opinion, the number of licensed producers doesn't matter to investors. It's the publicly traded ones that matter. Those are the hot commodity. So in that sense, our licenses won't devalue. When everyone wants to get rich off legal pot, they won't be walking into "Joe's Cannabis Cafe" and handing him $10k to invest. But they will most certainly be scrambling to buy into anything publicly traded. Only when the market is flooded with public LPs will we need to worry about devaluation of the licenses.
Creedman wrote: Even tho the post does not make sense he's not that wrong Droid, A month ago we had 38, today we have 50 and it keeps growing, which devalues our licenses. Don't get me wrong, 12 is not a ton to worry about, but....at the rate HC is approving applications that 50 will be jumping quickly too.

droidmeister wrote: So many more licensed producers?? Since when? Cut the BS troll - here's the accurate list on Health Canada's web-site, where's the "so many more" producers?:

https://www.canada.ca/en/health-canada/services/drugs-health-products/medical-use-marijuana/licensed-producers/authorized-licensed-producers-medical-purposes.html

LuckyyCharms wrote: We have approched a new time and new sector. So much more producers than THC Biomed. Interested buyer have much Licensed Producers to choose from. New strike resources ( Hemisphere Pharma.) HIP is at the levels approched now. What can we improve on aa holders? Is more of a reason to believe in why lower stock?

 

 




Bullboard Posts